- Home
- LMFA vs LGVN Comparison
LMFA vs LGVN Comparison
Compare LMFA & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMFA
- LGVN
- Stock Information
- Founded
- LMFA 2008
- LGVN 2014
- Country
- LMFA United States
- LGVN United States
- Employees
- LMFA N/A
- LGVN N/A
- Industry
- LMFA Finance: Consumer Services
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- LMFA Finance
- LGVN Health Care
- Exchange
- LMFA Nasdaq
- LGVN Nasdaq
- Market Cap
- LMFA 15.5M
- LGVN 17.6M
- IPO Year
- LMFA 2015
- LGVN 2021
- Fundamental
- Price
- LMFA $0.83
- LGVN $0.63
- Analyst Decision
- LMFA Strong Buy
- LGVN Strong Buy
- Analyst Count
- LMFA 1
- LGVN 2
- Target Price
- LMFA $5.00
- LGVN $6.50
- AVG Volume (30 Days)
- LMFA 2.2M
- LGVN 424.7K
- Earning Date
- LMFA 11-14-2025
- LGVN 11-04-2025
- Dividend Yield
- LMFA N/A
- LGVN N/A
- EPS Growth
- LMFA N/A
- LGVN N/A
- EPS
- LMFA N/A
- LGVN N/A
- Revenue
- LMFA $7,567,508.00
- LGVN $1,437,000.00
- Revenue This Year
- LMFA N/A
- LGVN N/A
- Revenue Next Year
- LMFA $15.59
- LGVN N/A
- P/E Ratio
- LMFA N/A
- LGVN N/A
- Revenue Growth
- LMFA N/A
- LGVN N/A
- 52 Week Low
- LMFA $0.78
- LGVN $0.61
- 52 Week High
- LMFA $5.14
- LGVN $2.24
- Technical
- Relative Strength Index (RSI)
- LMFA 38.61
- LGVN 25.97
- Support Level
- LMFA $0.78
- LGVN $0.62
- Resistance Level
- LMFA $1.14
- LGVN $0.79
- Average True Range (ATR)
- LMFA 0.13
- LGVN 0.05
- MACD
- LMFA -0.02
- LGVN -0.02
- Stochastic Oscillator
- LMFA 11.22
- LGVN 2.78
About LMFA LM Funding America Inc.
LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.